Quick Takeaways
- Pentwater Capital Management LP filed SCHEDULE 13G for Centessa Pharmaceuticals plc Ordinary Shares, nominal value GBP 0.002 per share (CNTA).
- Disclosed ownership: 5.3%.
- Date of event: 31 Mar 2026.
Pentwater Capital Management LP - 31 Mar 2026 SCHEDULE 13G Report for Centessa Pharmaceuticals plc Ordinary Shares, nominal value GBP 0.002 per share (CNTA)
- Filing Manager
- Pentwater Capital Management LP
- Reporting Manager
- Pentwater Capital Management LP
- Symbol
- CNTA
- Shares outstanding
- 154,150,943 shares
- Disclosed Ownership
- 8,170,000 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G
- Filing time
- 15 May 2026, 16:32:00 UTC
- Date of event
- 31 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Pentwater Capital Management LP disclosed 5.3% ownership in Centessa Pharmaceuticals plc Ordinary Shares, nominal value GBP 0.002 per share (CNTA) on 31 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2026, 16:32.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Pentwater Capital Management LP | 5.3% | 8,170,000 | 0 | 8,170,000 | /s/ Matthew Halbower | By: MCH PWCM Holdings Inc., General Partner, By: Matthew Halbower, Chief Executive Officer | |
| Matthew Halbower | 5.3% | 8,170,000 | 0 | 8,170,000 | /s/ Matthew Halbower | Matthew Halbower, Individually |